Schiele Felix, Ayaz Pelin, Fernández-Montalván Amaury
Assay Development-High-Throughput Screening, Department of Lead Discovery Berlin, Bayer HealthCare, 13353 Berlin, Germany.
Protein Technologies, Global Drug Discovery, Department of Lead Discovery Berlin, Bayer HealthCare, 13353 Berlin, Germany.
Anal Biochem. 2015 Jan 1;468:42-9. doi: 10.1016/j.ab.2014.09.007. Epub 2014 Sep 18.
There is an increasing demand for assay technologies that enable accurate, cost-effective, and high-throughput measurements of drug-target association and dissociation rates. Here we introduce a universal homogeneous kinetic probe competition assay (kPCA) that meets these requirements. The time-resolved fluorescence energy transfer (TR-FRET) procedure combines the versatility of radioligand binding assays with the advantages of homogeneous nonradioactive techniques while approaching the time resolution of surface plasmon resonance (SPR) and related biosensors. We show application of kPCA for three important target classes: enzymes, protein-protein interactions, and G protein-coupled receptors (GPCRs). This method is capable of supporting early stages of drug discovery with large amounts of kinetic information.
对于能够实现对药物-靶点结合和解离速率进行准确、经济高效且高通量测量的分析技术的需求日益增长。在此,我们介绍一种满足这些要求的通用均相动力学探针竞争分析方法(kPCA)。时间分辨荧光能量转移(TR-FRET)程序将放射性配体结合分析的多功能性与均相非放射性技术的优势相结合,同时接近表面等离子体共振(SPR)及相关生物传感器的时间分辨率。我们展示了kPCA在三类重要靶点中的应用:酶、蛋白质-蛋白质相互作用以及G蛋白偶联受体(GPCR)。该方法能够凭借大量的动力学信息支持药物发现的早期阶段。